Association of Interleukin 8 and Myocardial Recovery in Patients with ST-Elevation Myocardial Infarction Complicated by Acute Heart Failure

被引:37
作者
Husebye, Trygve [1 ,3 ,4 ]
Eritsland, Jan [1 ,3 ]
Arnesen, Harald [2 ,3 ,4 ]
Bjornerheim, Reidar [1 ,3 ]
Mangschau, Arild [1 ,3 ]
Seljeflot, Ingebjorg [1 ,2 ,3 ,4 ]
Andersen, Geir Oystein [1 ,2 ,3 ]
机构
[1] Univ Oslo, Hosp Ulleval, Dept Cardiol, Oslo, Norway
[2] Univ Oslo, Hosp Ulleval, Ctr Clin Heart Res, Oslo, Norway
[3] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway
[4] Univ Oslo, Fac Med, Oslo, Norway
关键词
PERCUTANEOUS CORONARY INTERVENTION; CYTOKINE LEVELS; LEVOSIMENDAN; DYSFUNCTION; RECEPTORS; TRIAL;
D O I
10.1371/journal.pone.0112359
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: No data from controlled trials exists regarding the inflammatory response in patients with de novo heart failure (HF) complicating ST-elevation myocardial infarction (STEMI) and a possible role in the recovery of contractile function. We therefore explored the time course and possible associations between levels of inflammatory markers and recovery of impaired left ventricular function as well as levosimendan treatment in STEMI patients in a substudy of the LEvosimendan in Acute heart Failure following myocardial infarction (LEAF) trial. Methods: A total of 61 patients developing HF within 48 hours after a primary PCI-treated STEMI were randomised double-blind to a 25 hours infusion of levosimendan or placebo. Levels of IL-6, CRP, sIL-6R, sgp130, MCP-1, IL-8, MMP-9, sICAM-1, sVCAM-1 and TNF-alpha were measured at inclusion (median 22 h, interquartile range (IQR) 14, 29 after PCI), on day 1, day 2, day 5 and 6 weeks. Improvement in left ventricular function was evaluated as change in wall motion score index (WMSI) by echocardiography. Results: Only circulating levels of IL-8 at inclusion were associated with change in WMSI from baseline to 6 weeks, r = divided by 0.41 (p = 0.002). No association, however, was found between IL-8 and WMSI at inclusion or peak troponin T. Furthermore, there was a significant difference in change in WMSI from inclusion to 6 weeks between patients with IL-8 levels below, compared to above median value, divided by 0.44 (IQR divided by 0.57, divided by 0.19) vs. divided by 0.07 (IQR divided by 0.27, 0.07), respectively (p<0.0001). Levosimendan did not affect the levels of inflammary markers compared to control. Conclusion: High levels of IL-8 in STEMI patients complicated with HF were associated with less improvement in left ventricular function during the first 6 weeks after PCI, suggesting a possible role of IL-8 in the reperfusion-related injury of post-ischemic myocardium. Further studies are needed to confirm this hypothesis.
引用
收藏
页数:8
相关论文
共 28 条
[1]
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size [J].
Andersen, Geir Oystein ;
Knudsen, Eva Cecilie ;
Aukrust, Pal ;
Yndestad, Arne ;
Oie, Erik ;
Muller, Carl ;
Seljeflot, Ingebjorg ;
Ueland, Thor .
HEART, 2011, 97 (06) :460-465
[2]
The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine [J].
Avgeropoulou, C ;
Andreadou, I ;
Markantonis-Kyroudis, S ;
Demopoulou, M ;
Missovoulos, P ;
Androulakis, A ;
Kallikazaros, I .
EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (05) :882-887
[3]
Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction [J].
Bolognese, L ;
Carrabba, N ;
Parodi, G ;
Santoro, GM ;
Buonamici, P ;
Cerisano, G ;
Antoniucci, D .
CIRCULATION, 2004, 109 (09) :1121-1126
[4]
Chen David, 2008, Crit Care Med, V36, pS9, DOI 10.1097/01.CCM.0000297160.48694.90
[5]
Deswal A, 2001, CIRCULATION, V103, P2055
[6]
The inflammatory response in myocardial infarction [J].
Frangogiannis, NG ;
Smith, CW ;
Entman, ML .
CARDIOVASCULAR RESEARCH, 2002, 53 (01) :31-47
[7]
Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction [J].
Gerber, BL ;
Rochitte, CE ;
Melin, JA ;
McVeigh, ER ;
Bluemke, DA ;
Wu, KC ;
Becker, LC ;
Lima, JAC .
CIRCULATION, 2000, 101 (23) :2734-2741
[8]
Infarct size measured by single photon emission computed tomographic imaging with 99mTc-sestamibi -: A measure of the efficacy of therapy in acute myocardial infarction [J].
Gibbons, RJ ;
Miller, TD ;
Christian, TF .
CIRCULATION, 2000, 101 (01) :101-108
[9]
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology [J].
Heymans, Stephane ;
Hirsch, Emilio ;
Anker, Stefan D. ;
Aukrust, Pal ;
Balligand, Jean-Luc ;
Cohen-Tervaert, Jan W. ;
Drexler, Helmut ;
Filippatos, Gerasimos ;
Felix, Stephan B. ;
Gullestad, Lars ;
Hilfiker-Kleiner, Denise ;
Janssens, Stefan ;
Latini, Roberto ;
Neubauer, Gitte ;
Paulus, Walter J. ;
Pieske, Burkert ;
Ponikowski, Piotr ;
Schroen, Blanche ;
Schultheiss, Heinz-Peter ;
Tschoepe, Carsten ;
Van Bilsen, Marc ;
Zannad, Faiez ;
McMurray, John ;
Shah, Ajay M. .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (02) :119-129
[10]
Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study [J].
Husebye, Trygve ;
Eritsland, Jan ;
Muller, Carl ;
Sandvik, Leiv ;
Arnesen, Harald ;
Seljeflot, Ingebjorg ;
Mangschau, Arild ;
Bjornerheim, Reidar ;
Andersen, Geir Oystein .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (05) :565-572